$291 Million is the total value of Defender Capital, LLC.'s 37 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 16.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VGSH | Buy | VANGUARD SHORT TERM TREASURY ETF IVetf | $69,514,391 | +7.5% | 1,204,145 | +9.1% | 23.90% | +5.9% |
DHR | Buy | DANAHER CORPORATION | $34,579,651 | -3.9% | 144,082 | +1.0% | 11.89% | -5.3% |
FTV | Buy | FORTIVE CORP | $30,008,503 | +16.0% | 401,398 | +5.8% | 10.32% | +14.2% |
STAA | Buy | STAAR SURGICAL CO | $27,197,159 | -13.5% | 517,352 | +5.3% | 9.35% | -14.8% |
TDY | Buy | TELEDYNE TECHNOLOGIES INC | $14,679,380 | -3.8% | 35,707 | +4.7% | 5.05% | -5.2% |
COST | Buy | COSTCO WHSL CORP | $9,222,578 | +11.6% | 17,130 | +3.0% | 3.17% | +9.9% |
PLTR | Buy | PALANTIR TECHNOLOGIES INC | $5,175,488 | +88.8% | 337,540 | +4.1% | 1.78% | +85.9% |
BE | Buy | BLOOM ENERGY CORP | $2,605,555 | -14.4% | 159,300 | +4.3% | 0.90% | -15.7% |
AMZN | Buy | AMAZON COM INC | $664,836 | +29.8% | 5,100 | +2.8% | 0.23% | +27.9% |
PFE | New | PFIZER INC | $657,856 | – | 17,935 | +100.0% | 0.23% | – |
JPM | Buy | JPMORGAN CHASE & CO | $270,082 | +12.1% | 1,857 | +0.4% | 0.09% | +10.7% |
CSX | Buy | CSX CORP | $236,586 | +14.4% | 6,938 | +0.4% | 0.08% | +12.5% |
JNJ | Buy | JOHNSON & JOHNSON | $226,597 | +7.0% | 1,369 | +0.2% | 0.08% | +5.4% |
New | 374WATER INC | $222,270 | – | 93,000 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-07-18
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL CL B | 20 | Q3 2023 | 24.4% |
DANAHER CORPORATION COM | 20 | Q3 2023 | 18.3% |
STAAR SURGICAL CORPORATION | 20 | Q3 2023 | 20.2% |
FORTIVE CORPORATION | 20 | Q3 2023 | 14.3% |
MONSTER BEVERAGE CORPORATION | 20 | Q3 2023 | 17.3% |
APPLE INC | 20 | Q3 2023 | 0.6% |
AMAZON INC COM | 20 | Q3 2023 | 0.4% |
VANGUARD SHORT TERM TREASURY ETF IV | 17 | Q3 2023 | 23.9% |
LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 4.8% |
COMPUGEN LTD ORD | 17 | Q1 2023 | 1.9% |
View Defender Capital, LLC.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-06 |
13F-HR | 2024-01-23 |
13F-HR | 2023-10-23 |
13F-HR | 2023-07-18 |
13F-HR/A | 2023-05-16 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-12 |
13F-HR | 2022-10-18 |
13F-HR | 2022-07-26 |
13F-HR/A | 2022-06-07 |
View Defender Capital, LLC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.